Tower Research Capital (TRC)’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-505
| Closed | -$10K | – | 6721 |
|
|
2022
Q4 | $10K | Buy |
505
+463
| +1,102% | +$9.17K | ﹤0.01% | 4138 |
|
|
2022
Q3 | $1K | Sell |
42
-808
| -95% | -$19.2K | ﹤0.01% | 5953 |
|
|
2022
Q2 | $27K | Sell |
850
-3,248
| -79% | -$103K | ﹤0.01% | 3495 |
|
|
2022
Q1 | $167K | Buy |
4,098
+2,523
| +160% | +$103K | ﹤0.01% | 1859 |
|
|
2021
Q4 | $70K | Buy |
1,575
+678
| +76% | +$30.1K | ﹤0.01% | 2496 |
|
|
2021
Q3 | $45K | Buy |
+897
| New | +$45K | ﹤0.01% | 3055 |
|
|
2021
Q2 | – | Sell |
-17
| Closed | -$1K | – | 6065 |
|
|
2021
Q1 | $1K | Sell |
17
-83
| -83% | -$4.88K | ﹤0.01% | 5265 |
|
|
2020
Q4 | $5K | Sell |
100
-5,507
| -98% | -$275K | ﹤0.01% | 4666 |
|
|
2020
Q3 | $249K | Buy |
5,607
+3,372
| +151% | +$150K | ﹤0.01% | 2360 |
|
|
2020
Q2 | $86K | Sell |
2,235
-1,326
| -37% | -$51K | ﹤0.01% | 2606 |
|
|
2020
Q1 | $146K | Buy |
+3,561
| New | +$146K | 0.01% | 871 |
|